Tollervey patent opposition analysis

The comprehensive analysis of Tollervey opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Tollervey

Patent NumberTitleApplicantOpposition DateOpposition Company
Cd33 Binding AgentsBOEHRINGER INGELHEIMJun 7, 2017STRAWMAN
Prolongation Of Survival Of An Allograft By Inhibiting Complement ActivityALEXION PHARMACEUTICALSSep 12, 2015F HOFFMANN LA ROCHE CHUGAI PHARMACEUTICAL

Top companies who are the clients of Tollervey